JPS518260A - - Google Patents

Info

Publication number
JPS518260A
JPS518260A JP50069250A JP6925075A JPS518260A JP S518260 A JPS518260 A JP S518260A JP 50069250 A JP50069250 A JP 50069250A JP 6925075 A JP6925075 A JP 6925075A JP S518260 A JPS518260 A JP S518260A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50069250A
Other languages
Japanese (ja)
Other versions
JPS5840557B2 (ja
Inventor
Pateri Bianka
Berunarudei Ruiji
Arukamone Fuederiko
Ji Maruko Aurerio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Publication of JPS518260A publication Critical patent/JPS518260A/ja
Publication of JPS5840557B2 publication Critical patent/JPS5840557B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP50069250A 1974-06-12 1975-06-10 ダウノマイシンルイエンタイノセイホウ Expired JPS5840557B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2608374A GB1467383A (en) 1974-06-12 1974-06-12 Daunomycin analogues

Publications (2)

Publication Number Publication Date
JPS518260A true JPS518260A (cg-RX-API-DMAC7.html) 1976-01-23
JPS5840557B2 JPS5840557B2 (ja) 1983-09-06

Family

ID=10238087

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50069250A Expired JPS5840557B2 (ja) 1974-06-12 1975-06-10 ダウノマイシンルイエンタイノセイホウ

Country Status (17)

Country Link
US (1) US4046878A (cg-RX-API-DMAC7.html)
JP (1) JPS5840557B2 (cg-RX-API-DMAC7.html)
AT (1) AT337363B (cg-RX-API-DMAC7.html)
BE (1) BE830090A (cg-RX-API-DMAC7.html)
BG (1) BG61059B2 (cg-RX-API-DMAC7.html)
CH (1) CH611317A5 (cg-RX-API-DMAC7.html)
DE (2) DE19375027I2 (cg-RX-API-DMAC7.html)
DK (1) DK147304C (cg-RX-API-DMAC7.html)
ES (1) ES438431A1 (cg-RX-API-DMAC7.html)
FR (1) FR2274629A1 (cg-RX-API-DMAC7.html)
GB (1) GB1467383A (cg-RX-API-DMAC7.html)
HK (1) HK982A (cg-RX-API-DMAC7.html)
MY (1) MY103666A (cg-RX-API-DMAC7.html)
NL (1) NL173272C (cg-RX-API-DMAC7.html)
SE (1) SE423633B (cg-RX-API-DMAC7.html)
SU (1) SU645588A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA753722B (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5673039A (en) * 1979-08-20 1981-06-17 Hoffmann La Roche Naphthacene derivative
JPS5753497A (en) * 1980-07-18 1982-03-30 Hoffmann La Roche Novel anthracycline glycoside

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
GB1509875A (en) * 1976-06-14 1978-05-04 Farmaceutici Italia Optically active anthracyclinones and anthracycline glycosides
US4161480A (en) * 1978-06-05 1979-07-17 G. D. Searle & Co. Intermediates for the synthesis of 4-demethoxydaunorubicin
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
IL55431A (en) * 1978-08-24 1982-07-30 Yeda Res & Dev Anthracycline type antibiotics,their preparation and pharmaceutical compositions comprising them
NL8001417A (nl) * 1979-03-17 1980-09-19 Erba Farmitalia Antitumorglycosiden.
ATE1101T1 (de) * 1979-09-01 1982-06-15 Farmitalia Carlo Erba S.P.A. Anthracyclin-glycoside, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzung.
DE3100968A1 (de) * 1980-01-16 1982-01-14 Farmitalia Carlo Erba S.p.A., 20159 Milano Anthracyclinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4348388A (en) * 1980-04-02 1982-09-07 G.D. Searle & Co. 11-Amino-11-deoxydaunorubicin and analogs
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.
GB8317037D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia 6-deoxyanthracyclines
US5138042A (en) * 1981-05-28 1992-08-11 Farmitalia Carlo Erba S.P.A. 6-deoxyanthracyclines
US4563444A (en) * 1982-05-26 1986-01-07 Farmitalia Carlo Erba S.P.A. Anthracycline glycosides, use and compositions containing same
US4604381A (en) * 1982-07-16 1986-08-05 Farmitalia Carlo Erba S.P.A. 4-demethoxy-13-dihydrodaunorubicin and use thereof
US4562177A (en) * 1982-08-17 1985-12-31 The Ohio State University Research Foundation 3'-Amino-2' halo-anthracycline antibiotics
US4564674A (en) * 1983-10-31 1986-01-14 Sagami Chemical Research Center Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process
US4496485A (en) * 1983-11-25 1985-01-29 G. D. Searle & Co. Asymmetric 7-O-(substituted acetyl)-4-demethoxydaunomycinones
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
US4697005A (en) * 1985-03-20 1987-09-29 Ohio State University Research Foundation 1-fluoro, 4-fluoro, and 1,4-difluoro anthracycline anticancer antibiotics
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
NZ224252A (en) * 1987-04-21 1991-09-25 Erba Carlo Spa An anthracycline glycoside and its preparation
JPS63191263U (cg-RX-API-DMAC7.html) * 1987-05-29 1988-12-09
GB2212154B (en) * 1987-11-10 1991-03-27 Erba Carlo Spa New 4-demethoxy anthracycline derivatives
GB8803301D0 (en) * 1988-02-12 1988-03-09 Erba Carlo Spa Process for preparation of 4-demethoxy-daunomycinone aglycone of 4-demethoxy-daunorubicin
GB8808475D0 (en) * 1988-04-11 1988-05-11 Erba Carlo Spa Process for preparing 4-demethoxydauno-mycinone
GB8818167D0 (en) * 1988-07-29 1988-09-01 Erba Carlo Spa Novel 4-substituted anthracyclinones & process for their preparation
JP2563080B2 (ja) * 1992-03-02 1996-12-11 フアイザー・インコーポレイテツド マクロライドの糖誘導体
AU2003299378A1 (en) * 2002-10-11 2004-05-04 Board Of Regents, The University Of Texas System Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
CN101146532B (zh) 2005-01-21 2012-05-09 阿斯泰克斯治疗有限公司 药物化合物
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
BRPI0923815A2 (pt) * 2008-12-23 2015-07-14 Pharmasset Inc Síntese de nucleosídeos de purina
EP2376514A2 (en) * 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
EA019341B1 (ru) * 2008-12-23 2014-02-28 Джилид Фармассет, Ллс. Фосфорамидаты нуклеозидов
PL2719708T3 (pl) 2009-11-13 2018-04-30 Daiichi Sankyo Europe Gmbh Materiał i sposoby leczenia lub zapobiegania chorobom związanym z HER-3
LT2609923T (lt) 2010-03-31 2017-09-11 Gilead Pharmasset Llc (s)-izopropilo 2-(((s)-(perfluorfenoksi)(fenoksi)fosforil)amino)-propanoato kristalinimo būdas
WO2012018404A2 (en) 2010-08-06 2012-02-09 U3 Pharma Gmbh Use of her3 binding agents in prostate treatment
DE102011113652A1 (de) 2011-09-19 2013-03-21 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Idarubicinhydrochlorid
DK3311827T3 (da) 2011-10-03 2023-04-03 Canqura Oncology Ab Nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf som bærere for amfipatiske eller hydrofobe molekyler inden for det medicinske område, inklusiv cancerbehandling, samt fødevarerelaterede forbindelser
US9907846B2 (en) 2013-04-01 2018-03-06 Mx Adjuvac Ab Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
EP3669890A1 (en) 2018-12-18 2020-06-24 Croda International PLC Filamentous nanoparticles having vaccine adjuvant effect

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3427300A (en) * 1965-11-12 1969-02-11 Merck & Co Inc Anti-inflammatory steroid 2'-acetamido-2'-deoxy-glucoside compounds
US3803124A (en) * 1968-04-12 1974-04-09 Farmaceutici It Soc Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
US3686163A (en) * 1968-05-14 1972-08-22 Farmaceutici Italia Dihydrodaunomycin antibiotic and derivatives thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5673039A (en) * 1979-08-20 1981-06-17 Hoffmann La Roche Naphthacene derivative
JPS5753497A (en) * 1980-07-18 1982-03-30 Hoffmann La Roche Novel anthracycline glycoside

Also Published As

Publication number Publication date
SU645588A3 (ru) 1979-01-30
JPS5840557B2 (ja) 1983-09-06
SE423633B (sv) 1982-05-17
AT337363B (de) 1977-06-27
DK147304B (da) 1984-06-12
DE2525633A1 (de) 1976-01-02
NL173272B (nl) 1983-08-01
BG61059B2 (bg) 1996-09-30
CH611317A5 (cg-RX-API-DMAC7.html) 1979-05-31
SE7506589L (sv) 1975-12-15
ATA437375A (de) 1976-10-15
GB1467383A (en) 1977-03-16
ES438431A1 (es) 1977-02-01
HK982A (en) 1982-01-22
DE19375027I2 (de) 2002-06-13
NL173272C (nl) 1984-01-02
AU8197975A (en) 1976-12-16
US4046878A (en) 1977-09-06
ZA753722B (en) 1976-09-29
BE830090A (fr) 1975-12-11
FR2274629B1 (cg-RX-API-DMAC7.html) 1980-01-11
DK256875A (da) 1975-12-13
DE2525633B2 (cg-RX-API-DMAC7.html) 1979-03-01
DE2525633C3 (cg-RX-API-DMAC7.html) 1979-10-18
NL7506745A (nl) 1975-12-16
FR2274629A1 (fr) 1976-01-09
DK147304C (da) 1984-12-17
MY103666A (en) 1993-08-28

Similar Documents

Publication Publication Date Title
FR2274629B1 (cg-RX-API-DMAC7.html)
FR2258080A1 (cg-RX-API-DMAC7.html)
FI750699A7 (cg-RX-API-DMAC7.html)
AU495841B2 (cg-RX-API-DMAC7.html)
CS177094B2 (cg-RX-API-DMAC7.html)
DK415175A (cg-RX-API-DMAC7.html)
AU7459374A (cg-RX-API-DMAC7.html)
FI752856A7 (cg-RX-API-DMAC7.html)
FI750512A7 (cg-RX-API-DMAC7.html)
AU495898B2 (cg-RX-API-DMAC7.html)
DK135927C (cg-RX-API-DMAC7.html)
CS172011B1 (cg-RX-API-DMAC7.html)
CS169634B1 (cg-RX-API-DMAC7.html)
CS169166B1 (cg-RX-API-DMAC7.html)
CS161594B1 (cg-RX-API-DMAC7.html)
AU7465674A (cg-RX-API-DMAC7.html)
AU480578A (cg-RX-API-DMAC7.html)
CH613615A5 (cg-RX-API-DMAC7.html)
AU481898A (cg-RX-API-DMAC7.html)
AU480994A (cg-RX-API-DMAC7.html)
AU482149A (cg-RX-API-DMAC7.html)
AU480764A (cg-RX-API-DMAC7.html)
AU480758A (cg-RX-API-DMAC7.html)
AU482236A (cg-RX-API-DMAC7.html)
DD117548A1 (cg-RX-API-DMAC7.html)